News Conference News EuroPCR 2024 ORBITA-2: Angina Phenotype Strongly Predicts PCI Response Caitlin E. Cox May 15, 2024
News Conference News EuroPCR 2023 Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization Michael O'Riordan May 19, 2023
News Conference News EuroPCR 2021 Elective Revascularization, Better Long-term Survival: Meta-analysis Michael O'Riordan May 18, 2021
News Conference News EuroPCR 2020 No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms Michael O'Riordan June 26, 2020
News Conference News EuroPCR 2018 ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics Michael O'Riordan May 31, 2018
News Conference News EuroPCR 2018 Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions Michael O'Riordan May 23, 2018
News Conference News EuroPCR 2018 FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data Caitlin E. Cox May 22, 2018
News Conference News EuroPCR 2018 New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement Shelley Wood May 22, 2018
Presentation EuroPCR 2018 ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease Presenter: Rasha Al-Lamee May 22, 2018
News Conference News EuroPCR 2018 FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis Michael O'Riordan May 22, 2018
News Conference News EuroPCR 2018 EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage Shelley Wood May 17, 2018
News Conference News EuroPCR 2017 DISRUPT CAD: Lithoplasty May Modify Dense Calcium in Coronary Lesions Before Stenting Yael L. Maxwell May 22, 2017
News Conference News EuroPCR 2013 ORBIT II: Atherectomy System Shows Positive Results in Calcified Lesions Jason Kahn May 24, 2013